Perrigo Co. Plc (PRGO)
14.28
+0.03
(+0.21%)
USD |
NYSE |
Aug 24, 16:00
14.28
0.00 (0.00%)
After-Hours: 20:00
Perrigo Enterprise Value : 5.035B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.035B |
| August 20, 2026 | 4.959B |
| August 19, 2026 | 4.995B |
| August 18, 2026 | 4.858B |
| August 17, 2026 | 4.837B |
| August 14, 2026 | 4.868B |
| August 13, 2026 | 4.839B |
| August 12, 2026 | 4.819B |
| August 11, 2026 | 4.841B |
| August 10, 2026 | 4.812B |
| August 07, 2026 | 4.840B |
| August 06, 2026 | 4.798B |
| August 05, 2026 | 4.900B |
| August 04, 2026 | 4.554B |
| August 03, 2026 | 4.540B |
| July 31, 2026 | 4.461B |
| July 30, 2026 | 4.489B |
| July 29, 2026 | 4.506B |
| July 28, 2026 | 4.488B |
| July 27, 2026 | 4.465B |
| July 24, 2026 | 4.458B |
| July 23, 2026 | 4.460B |
| July 22, 2026 | 4.511B |
| July 21, 2026 | 4.511B |
| July 20, 2026 | 4.528B |
| Date | Value |
|---|---|
| July 17, 2026 | 4.546B |
| July 16, 2026 | 4.607B |
| July 15, 2026 | 4.467B |
| July 14, 2026 | 4.432B |
| July 13, 2026 | 4.470B |
| July 10, 2026 | 4.477B |
| July 09, 2026 | 4.503B |
| July 08, 2026 | 4.518B |
| July 07, 2026 | 4.611B |
| July 06, 2026 | 4.597B |
| July 02, 2026 | 4.587B |
| July 01, 2026 | 4.489B |
| June 30, 2026 | 4.500B |
| June 29, 2026 | 4.836B |
| June 26, 2026 | 4.822B |
| June 25, 2026 | 4.785B |
| June 24, 2026 | 4.796B |
| June 23, 2026 | 4.759B |
| June 22, 2026 | 4.774B |
| June 18, 2026 | 4.864B |
| June 17, 2026 | 4.851B |
| June 16, 2026 | 4.922B |
| June 15, 2026 | 4.926B |
| June 12, 2026 | 4.966B |
| June 11, 2026 | 4.953B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 18.69B |
| GH Research Plc | 1.582B |
| Cosmo NV | -- |
| Viatris, Inc. | 31.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 88.50M |
| Revenue (Quarterly) | 1.023B |
| Total Expenses (Quarterly) | 934.30M |
| EPS Diluted (Quarterly) | 0.5337 |
| Gross Profit Margin (Quarterly) | 30.73% |
| Profit Margin (Quarterly) | 8.65% |
| Earnings Yield | -87.61% |
| Operating Earnings Yield | 13.41% |
| Normalized Earnings Yield | -24.09 |